Saturday 6 June 2026

One To Watch

Capricor

Company Overview

Want to Update your Company's Profile?


Latest Capricor News

Duchenne market to be an expensive place to be
24 January 2022
Nile Therapeutics will merge with Capricor to become new company focused on heart disease
8 July 2013
More Capricor news >


Today's issue

No changes to Takeda’s core financials, despite $2.5 billion legal provision
Pharmaceutical
No changes to Takeda’s core financials, despite $2.5 billion legal provision
5 June 2026
Generics
Russia aims to have generic of one of the most expensive cystic fibrosis drugs
5 June 2026
Pharmaceutical
An inconvenient truth? Japan, innovation, drug pricing, MFN
5 June 2026
Biotechnology
Phase III data show less kidney function decline with Voyxact in IgAN
5 June 2026
Biotechnology
Biogen’s salanersen gets Breakthrough Therapy designation in SMA
5 June 2026
Biotechnology
Pfizer signs AI drug discovery license with Chai Discovery
5 June 2026
Biotechnology
Kairos Pharma adds NSCLC asset to portfolio
5 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze